Cargando…
Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
Helicobacter pylori (H. pylori) is a life-threatening pathogen which causes chronic gastritis, gastric ulcers and even stomach cancer. Treatment normally involves bacterial eradication; however, this type of treatment only has a rate of effectiveness of <80%. Thus, it is a matter of some urgency...
Autores principales: | YUAN, YUPING, WU, QINYI, CHENG, GUOXIANG, LIU, XUEFANG, LIU, SIGUO, LUO, JUAN, ZHANG, AIMIN, BIAN, LI, CHEN, JIANQUAN, LV, JIAJUN, DONG, XIANGQIAN, YANG, GANG, ZHU, YUNZHEN, MA, LANQING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501646/ https://www.ncbi.nlm.nih.gov/pubmed/26080893 http://dx.doi.org/10.3892/ijmm.2015.2251 |
Ejemplares similares
-
Antimicrobial Effects of Lactoferrin against Helicobacter pylori Infection
por: Imoto, Ichiro, et al.
Publicado: (2023) -
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
por: Tolone, Salvatore, et al.
Publicado: (2012) -
Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C
por: Ma, Lanqing, et al.
Publicado: (2014) -
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study
por: Ciccaglione, Antonio Francesco, et al.
Publicado: (2019) -
Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection
por: Fulgione, Andrea, et al.
Publicado: (2016)